证券记录 · 已归档季度
WAT
Waters Corporation · Healthcare · Medical - Diagnostics & Research
21被追踪持有人
+1Δ持有人
20.77M持有股份
$6.22B报告持仓市值
+2新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +5.0% ·
股份流向 -1.8% ·
净新建仓位 0.0%
· 公式
持有人分散化：持有人数增多，合计持仓比例缩小。
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 181.83K | $78.81M | n/a | n/a |
| Q2 2026 | 160 | +2 | 69.70M | $26.70B | +7 | −7 |
| Q1 2026 | 163 | +5 | 66.62M | $20.68B | +11 | −7 |
| Q4 2025 | 157 | -1 | 42.72M | $16.21B | +1 | −1 |
| Q3 2025 | 21 | +1 | 20.77M | $6.22B | +2 | −2 |
| Q2 2025 | 18 | +1 | 20.33M | $7.10B | +1 | n/a |
| Q1 2025 | 14 | -1 | 6.37M | $2.34B | n/a | −1 |
| Q4 2024 | 15 | +1 | 6.13M | $2.27B | +1 | n/a |
| Q3 2024 | 13 | -2 | 2.92M | $1.05B | +1 | −3 |
| Q2 2024 | 15 | n/a | 2.95M | $853.36M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 7.66M | +3.3% | $2.30B | 0.0% | ▲ Add | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 6.07M | -7.6% | $1.82B | 0.0% | ▼ Trim | 2 | SEC ↗ ×20 |
| 3 | State Street Global Advisors ✦ (被动) | 2.68M | +0.1% | $803.35M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | Geode Capital Management ✦ (被动) | 1.58M | +2.1% | $473.26M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 5 | Morgan Stanley ✦ | 737.25K | n/a | $221.04M | 0.0% | n/c | 1 | SEC ↗ ×14 |
| 6 | JPMorgan Chase ✦ | 664.89K | n/a | $199.35M | 0.0% | n/c | 1 | SEC ↗ ×34 |
| 7 | Wellington Management ✦ | 363.53K | -20.8% | $108.99M | 0.0% | ▼ Trim | 6 | SEC ↗ ×4 |
| 8 | D. E. Shaw & Co. ✦ | 291.85K | +25433.6% | $87.50M | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Goldman Sachs Group ✦ | 183.52K | n/a | $55.02M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 10 | T. Rowe Price ✦ | 110.06K | +27.9% | $33.00M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | AQR Capital Management ✦ | 81.36K | -61.1% | $23.73M | 0.0% | ▼ Trim | 6 | SEC ↗ ×5 |
| 12 | Fidelity (FMR) ✦ | 73.99K | -29.8% | $22.18M | 0.0% | ▼ Trim | 2 | SEC ↗ ×3 |
| 13 | Gotham Asset Management ✦ | 70.31K | +78.6% | $21.08M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 49.62K | +1339.5% | $14.88M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 15 | PRIMECAP Management ✦ | 48.57K | -1.0% | $14.56M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 33.95K | -88.2% | $10.18M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Point72 Asset Management ✦ | 25.88K | 新增 | $7.76M | 0.0% | New | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 22.62K | -55.7% | $6.78M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 19 | Arrowstreet Capital ✦ | 18.89K | +111.7% | $5.66M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Two Sigma Investments ✦ | 3.48K | -91.1% | $1.04M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 1.48K | 新增 | $444,318 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $7.76M | 0.0% |
| Bridgewater Associates | $444,318 | 0.0% |
已清仓
| Norges Bank | $266.38M | 曾为 0.0% |
| Adage Capital Partners | $10.28M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,162 持有人, 92.59M 股份, $26.09B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据